The Biobanking Technology Market in the US is expanding as research institutions, pharmaceutical companies, biotechnology firms, hospitals, and academic organizations increasingly utilize biobanks to collect, process, preserve, and manage biological samples for research and clinical applications.
Market Overview
The Biobanking Technology Market size is expected to reach US$ 15.58 Billion by 2034 from US$ 7.8 Billion in 2025. The market is estimated to record a CAGR of 9.03% from 2026 to 2034.Growing biomedical research, increasing demand for high-quality biological specimens, expansion of precision medicine and genomics research, and advances in automated sample management are supporting market development. The increasing use of biological samples in drug discovery, biomarker research, and personalized healthcare is further creating opportunities across the market.
Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00027299
What is Driving the Biobanking Technology Market?
The growing importance of biological samples in biomedical research is a major factor driving the Biobanking Technology Market. Biobanks provide researchers with access to well-characterized specimens that can support disease research, biomarker discovery, drug development, genomics, and clinical studies. Increasing investment in precision medicine and personalized healthcare is generating demand for high-quality tissue, blood, DNA, RNA, and other biological samples. The adoption of automated storage systems, robotics, digital sample tracking, and laboratory information management systems is improving sample management and operational efficiency. In addition, increasing focus on sample quality, traceability, data security, and standardized biobanking procedures is encouraging organizations to adopt advanced technologies.
Which Region Leads the Biobanking Technology Market?
North America represents an important region in the Biobanking Technology Market, supported by advanced healthcare and research infrastructure, significant biotechnology investment, and a strong presence of pharmaceutical and academic research organizations. The US contributes significantly to regional development due to its extensive biobank networks, biomedical research activities, and adoption of automated laboratory technologies. Europe also represents a significant market, supported by established biobanking initiatives and research infrastructure. Asia Pacific is witnessing increasing opportunities as investments in healthcare research, genomics, precision medicine, and biobanking infrastructure continue to expand.
Which Segment Leads the Biobanking Technology Market?
The equipment and storage segment represents a major component of the Biobanking Technology Market due to the need for reliable long-term preservation of biological samples. Automated ultra-low-temperature freezers, cryogenic storage systems, refrigerators, and temperature-monitoring technologies are widely used to maintain sample integrity. Laboratory information management systems are also gaining importance by enabling sample identification, tracking, inventory management, and data integration. Increasing adoption of automated sample handling and retrieval systems is further supporting market development as biobanks seek to improve efficiency and reduce manual processing.
Which Companies are Prominent in the Biobanking Technology Market?
Prominent companies associated with the Biobanking Technology Market include:
Thermo Fisher
Tecan Group
Qiagen
Hamilton
Brooks Automation
TTP Labtech
VWR
Promega
Worthington
Chart Industries
BD
Merck
Micronic
Panasonic
These companies provide biobanking equipment, automated sample-management systems, laboratory technologies, preservation solutions, and related software and services.
What is Changing in 2026?
In 2026, the Biobanking Technology Market continues to evolve through greater adoption of automation, digital sample management, artificial intelligence-enabled data analysis, and advanced preservation technologies. Biobanks are increasingly integrating automated storage and retrieval systems with laboratory information management platforms to improve sample traceability and operational efficiency. Growing use of genomics, multi-omics, and precision medicine is also increasing demand for high-quality and well-characterized biological specimens. Greater emphasis on data governance, standardization, sample quality, and cybersecurity is further shaping technology adoption across modern biobanking facilities.
What are the Major Investment Opportunities?
Major investment opportunities are emerging in automated biobank systems, cryogenic and ultra-low-temperature storage, laboratory information management systems, robotic sample handling, and digital inventory platforms. Companies can explore opportunities in technologies that improve sample integrity, traceability, retrieval speed, and storage efficiency. Growing demand for genomic and personalized medicine research is also creating opportunities for specialized biobanking solutions designed for tissue, blood, nucleic acid, and other biological specimens. Investments in integrated software platforms, remote monitoring, automation, and data-management capabilities can further support innovation in biobanking infrastructure.
Related Reports
Anti-PD-1 MAb Market Growth, Demand Size by 2034
High Level Disinfection Services Market Size, Growth Trends by 2034
About US
The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.
Contact Us
Contact Person: Ankit Mathur
E-mail:ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876
Also Available in : Korean German Japanese French Chinese Italian Spanish
